Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

BACKGROUND & AIMS: Liver transplantation (LT) is the only available treatment for end-stage non-alcoholic fatty liver disease (NAFLD) (related decompensated cirrhosis and/or hepatocellular carcinoma). The aim of our study was to evaluate the risk of disease recurrence after LT and the factors in...

Descripción completa

Detalles Bibliográficos
Autores principales: Villeret, François, Dharancy, Sébastien, Erard, Domitille, Abergel, Armand, Barbier, Louise, Besch, Camille, Boillot, Olivier, Boudjema, Karim, Coilly, Audrey, Conti, Filomena, Corpechot, Christophe, Duvoux, Christophe, Faitot, François, Faure, Stéphanie, Francoz, Claire, Giostra, Emiliano, Gugenheim, Jean, Hardwigsen, Jean, Hilleret, Marie-Noëlle, Hiriart, Jean-Baptiste, Houssel-Debry, Pauline, Kamar, Nassim, Lassailly, Guillaume, Latournerie, Marianne, Pageaux, Georges-Philippe, Samuel, Didier, Vanlemmens, Claire, Saliba, Faouzi, Dumortier, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957774/
https://www.ncbi.nlm.nih.gov/pubmed/36852108
http://dx.doi.org/10.1016/j.jhepr.2022.100668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957774/
https://www.ncbi.nlm.nih.gov/pubmed/36852108
http://dx.doi.org/10.1016/j.jhepr.2022.100668

Ejemplares similares